BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

759 related articles for article (PubMed ID: 16445986)

  • 1. Ceramides in insulin resistance and lipotoxicity.
    Summers SA
    Prog Lipid Res; 2006 Jan; 45(1):42-72. PubMed ID: 16445986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance.
    Holland WL; Brozinick JT; Wang LP; Hawkins ED; Sargent KM; Liu Y; Narra K; Hoehn KL; Knotts TA; Siesky A; Nelson DH; Karathanasis SK; Fontenot GK; Birnbaum MJ; Summers SA
    Cell Metab; 2007 Mar; 5(3):167-79. PubMed ID: 17339025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.
    Black PH
    Med Hypotheses; 2006; 67(4):879-91. PubMed ID: 16781084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free fatty acids and skeletal muscle insulin resistance.
    Kraegen EW; Cooney GJ
    Curr Opin Lipidol; 2008 Jun; 19(3):235-41. PubMed ID: 18460913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    Caldwell SH; Ikura Y; Iezzoni JC; Liu Z
    J Gastroenterol Hepatol; 2007 Jun; 22 Suppl 1():S11-9. PubMed ID: 17567458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation.
    Lionetti L; Mollica MP; Lombardi A; Cavaliere G; Gifuni G; Barletta A
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):146-52. PubMed ID: 19171470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes, lipids, and adipocyte secretagogues.
    Faraj M; Lu HL; Cianflone K
    Biochem Cell Biol; 2004 Feb; 82(1):170-90. PubMed ID: 15052336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome: metabolic changes with vascular consequences.
    Wassink AM; Olijhoek JK; Visseren FL
    Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary modulators of peroxisome proliferator-activated receptors: implications for the prevention and treatment of metabolic syndrome.
    Guri AJ; Hontecillas R; Bassaganya-Riera J
    J Nutrigenet Nutrigenomics; 2008; 1(3):126-35. PubMed ID: 19776622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue and ceramide biosynthesis in the pathogenesis of obesity.
    Samad F; Badeanlou L; Shah C; Yang G
    Adv Exp Med Biol; 2011; 721():67-86. PubMed ID: 21910083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications.
    Cusi K
    Gastroenterology; 2012 Apr; 142(4):711-725.e6. PubMed ID: 22326434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
    Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
    Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondria, body fat and type 2 diabetes: what is the connection?
    Maasen JA
    Minerva Med; 2008 Jun; 99(3):241-51. PubMed ID: 18497722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of lipids in the pathogenesis of muscle insulin resistance and beta cell failure in type II diabetes and obesity.
    Kraegen EW; Cooney GJ; Ye JM; Thompson AL; Furler SM
    Exp Clin Endocrinol Diabetes; 2001; 109 Suppl 2():S189-201. PubMed ID: 11460570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscular diacylglycerol metabolism and insulin resistance.
    Timmers S; Schrauwen P; de Vogel J
    Physiol Behav; 2008 May; 94(2):242-51. PubMed ID: 18207474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular mechanisms of insulin resistance and associated diseases.
    Mlinar B; Marc J; Janez A; Pfeifer M
    Clin Chim Acta; 2007 Jan; 375(1-2):20-35. PubMed ID: 16956601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic complications of obesity: inflated or inflamed?
    Chandalia M; Abate N
    J Diabetes Complications; 2007; 21(2):128-36. PubMed ID: 17331862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus.
    Heilbronn L; Smith SR; Ravussin E
    Int J Obes Relat Metab Disord; 2004 Dec; 28 Suppl 4():S12-21. PubMed ID: 15592481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.